3-43079574-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032806.6(POMGNT2):​c.*115C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00379 in 896,214 control chromosomes in the GnomAD database, including 76 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 56 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 20 hom. )

Consequence

POMGNT2
NM_032806.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.751

Publications

0 publications found
Variant links:
Genes affected
POMGNT2 (HGNC:25902): (protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)) This gene encodes a protein with glycosyltransferase activity although its function is not currently known. [provided by RefSeq, Sep 2012]
POMGNT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • myopathy caused by variation in POMGNT2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 3-43079574-G-T is Benign according to our data. Variant chr3-43079574-G-T is described in ClinVar as Benign. ClinVar VariationId is 1222363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0145 (2215/152334) while in subpopulation AFR AF = 0.0505 (2101/41564). AF 95% confidence interval is 0.0487. There are 56 homozygotes in GnomAd4. There are 1028 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 56 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032806.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT2
NM_032806.6
MANE Select
c.*115C>A
3_prime_UTR
Exon 2 of 2NP_116195.2
POMGNT2
NM_001437285.1
c.*115C>A
3_prime_UTR
Exon 3 of 3NP_001424214.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT2
ENST00000344697.3
TSL:1 MANE Select
c.*115C>A
3_prime_UTR
Exon 2 of 2ENSP00000344125.2Q8NAT1
POMGNT2
ENST00000441964.1
TSL:4
c.*115C>A
3_prime_UTR
Exon 3 of 3ENSP00000408992.1Q8NAT1
POMGNT2
ENST00000686643.1
c.*115C>A
3_prime_UTR
Exon 4 of 4ENSP00000509123.1Q8NAT1

Frequencies

GnomAD3 genomes
AF:
0.0145
AC:
2208
AN:
152216
Hom.:
54
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0505
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00484
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0105
GnomAD4 exome
AF:
0.00159
AC:
1185
AN:
743880
Hom.:
20
Cov.:
10
AF XY:
0.00131
AC XY:
496
AN XY:
379052
show subpopulations
African (AFR)
AF:
0.0482
AC:
860
AN:
17858
American (AMR)
AF:
0.00417
AC:
89
AN:
21334
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15474
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33218
South Asian (SAS)
AF:
0.0000189
AC:
1
AN:
53030
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39774
Middle Eastern (MID)
AF:
0.00341
AC:
9
AN:
2640
European-Non Finnish (NFE)
AF:
0.000152
AC:
80
AN:
524902
Other (OTH)
AF:
0.00410
AC:
146
AN:
35650
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
60
120
180
240
300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0145
AC:
2215
AN:
152334
Hom.:
56
Cov.:
33
AF XY:
0.0138
AC XY:
1028
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0505
AC:
2101
AN:
41564
American (AMR)
AF:
0.00477
AC:
73
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68034
Other (OTH)
AF:
0.0104
AC:
22
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
107
214
322
429
536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00372
Hom.:
2
Bravo
AF:
0.0167
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.6
DANN
Benign
0.47
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75583919; hg19: chr3-43121066; API